Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that ...

Surrozen will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. Other ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor technology for use in clinical trials and patient monitoring ...

The firm had trial successes in several high-profile product liability matters, and demand for energy work around the globe was brisk.

The firm had trial successes in several high-profile product liability matters, and demand for energy work around the globe was brisk.

In a report released today, Saket Kalia from Barclays maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of ...

Company Logo Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes ...

Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Brain Ischemia Market" report has been added to ResearchAndMarkets.com's offering. The competitive landscape of the brain ischemia market is shaped ...

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1 ...

Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Brain Ischemia Market" report has been added to ResearchAndMarkets.com's offering. The competitive landscape of the brain ischemia market is shaped by ...